Ronan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, Jennifer Carew, & Francis Giles. (2009). Nilotinib: Optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. Dove Medical Press.
Chicago Style (17th ed.) CitationRonan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, Jennifer Carew, and Francis Giles. Nilotinib: Optimal Therapy for Patients with Chronic Myeloid Leukemia and Resistance or Intolerance to Imatinib. Dove Medical Press, 2009.
MLA (9th ed.) CitationRonan Swords, et al. Nilotinib: Optimal Therapy for Patients with Chronic Myeloid Leukemia and Resistance or Intolerance to Imatinib. Dove Medical Press, 2009.
Warning: These citations may not always be 100% accurate.